[
  {
    "id": "902feca70804fc14",
    "title": "Ensysce Biosciences advances phase 3 trial for abuse-resistant opioid",
    "link": "https://www.investing.com/news/company-news/ensysce-biosciences-advances-phase-3-trial-for-abuseresistant-opioid-93CH-4429784",
    "summary": "",
    "body": null,
    "image": "https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg",
    "pubDate": "2026-01-05T13:14:03.000Z",
    "source": {
      "name": "Investing.com News (EN)",
      "homepage": "https://www.investing.com/rss/news.rss"
    },
    "lang": "en",
    "category": "science",
    "region": "global"
  }
]